je.st
news
The Wall Street Journal: Merck drug shrank tumors in some breast cancer patients in trial
2014-12-10 16:19:02| Biotech - Topix.net
A Merck & Co. drug shrank tumors in about 18.5% of women with an aggressive form of breast cancer in a small clinical trial, an early sign of the potential of immunotherapy to treat breast tumors.
Tags: street
journal
trial
wall
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||